1. Home
  2. PAHC vs ATRC Comparison

PAHC vs ATRC Comparison

Compare PAHC & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • ATRC
  • Stock Information
  • Founded
  • PAHC 1946
  • ATRC 2000
  • Country
  • PAHC United States
  • ATRC United States
  • Employees
  • PAHC N/A
  • ATRC N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • ATRC Medical/Dental Instruments
  • Sector
  • PAHC Health Care
  • ATRC Health Care
  • Exchange
  • PAHC Nasdaq
  • ATRC Nasdaq
  • Market Cap
  • PAHC 1.5B
  • ATRC 1.7B
  • IPO Year
  • PAHC 2014
  • ATRC 2005
  • Fundamental
  • Price
  • PAHC $38.81
  • ATRC $36.55
  • Analyst Decision
  • PAHC Hold
  • ATRC Strong Buy
  • Analyst Count
  • PAHC 4
  • ATRC 10
  • Target Price
  • PAHC $27.50
  • ATRC $49.60
  • AVG Volume (30 Days)
  • PAHC 256.6K
  • ATRC 343.3K
  • Earning Date
  • PAHC 11-05-2025
  • ATRC 10-29-2025
  • Dividend Yield
  • PAHC 1.27%
  • ATRC N/A
  • EPS Growth
  • PAHC 1895.04
  • ATRC N/A
  • EPS
  • PAHC 1.19
  • ATRC N/A
  • Revenue
  • PAHC $1,296,215,000.00
  • ATRC $499,946,000.00
  • Revenue This Year
  • PAHC $14.80
  • ATRC $16.32
  • Revenue Next Year
  • PAHC $3.16
  • ATRC $12.37
  • P/E Ratio
  • PAHC $31.66
  • ATRC N/A
  • Revenue Growth
  • PAHC 27.37
  • ATRC 16.28
  • 52 Week Low
  • PAHC $16.16
  • ATRC $27.32
  • 52 Week High
  • PAHC $41.57
  • ATRC $43.11
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 57.53
  • ATRC 55.80
  • Support Level
  • PAHC $35.81
  • ATRC $35.03
  • Resistance Level
  • PAHC $41.36
  • ATRC $36.83
  • Average True Range (ATR)
  • PAHC 1.31
  • ATRC 1.24
  • MACD
  • PAHC -0.40
  • ATRC 0.14
  • Stochastic Oscillator
  • PAHC 50.45
  • ATRC 84.48

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: